TrialClinical drug investigation2009

Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.

Andrew Wade et al.PubMed ↗Publisher ↗

No numbers read from the abstract.